Where are biostimulators placed?
In two patterns: deep, in the deep subcutaneous plane or on the periosteum of structural areas, to support the overlying tissue; or, for calcium hydroxylapatite, hyperdiluted and spread superficially under the skin to improve skin quality and firmness. The 2019 consensus on hyperdiluted calcium hydroxylapatite describes that second use explicitly as biostimulation rather than volumisation, with recommendations for the face, neck, décolletage and body areas covering insertion points, dosages and volumes for needle and cannula. The 2014 consensus on injectable poly-L-lactic acid covers patient selection, preparation and storage, injection technique and practical considerations.
A biostimulator does not fill in the way a hyaluronic acid gel does; it is placed where collagen is wanted over the following weeks. That makes plane and distribution the whole of the injection decision, and it makes dissection, which shows exactly where a dyed product spread, the most direct check of that decision outside a patient.
Which regions does the masterclass use, and what sits under each?
Five, from the day-two programme: malar and submalar region, pre-auricular area, jawline and lower-face laxity, neck and décolletage with hyperdiluted calcium hydroxylapatite, and the dorsum of the hand. The under-eyes and lips are excluded as regions where biostimulators must never be applied. The table lists, for each region, the use, the plane, what lies beneath or beside it and what a correct placement looks like.
| Region | Use | Plane | Beneath or beside | What correct placement looks like |
|---|---|---|---|---|
| Malar and submalar region | Structural support | Supraperiosteal or deep fat over the zygoma; deep subcutaneous below it | Zygomaticofacial nerve; transverse facial artery; parotid duct below the arch | Product deep to the SMAS, not in the superficial fat |
| Pre-auricular area | Lifting vectors for lower-face laxity | Subcutaneous, superficial to the SMAS and parotid | Facial nerve branches and the superficial temporal vessels deep to the SMAS | Product above the SMAS, not through it |
| Jawline and lower-face laxity | Structural support and vectorial lifting | Supraperiosteal along the mandibular border; subcutaneous fanning for laxity | Facial artery at the antegonial notch; marginal mandibular nerve, preperiosteal anterior to the masseter | Product on bone clear of the artery, with the nerve's course in mind |
| Neck and décolletage | Skin quality (hyperdiluted CaHA) | Superficial subcutaneous, spread thinly with a cannula | Platysma and the neck's deep structures beneath it | A thin, even layer under the skin, not pooled |
| Dorsum of the hand | Volume and skin quality | Subdermal, above the dorsal veins and extensor tendons | Dorsal veins; extensor tendons | Product in the loose subdermal layer, not around a vein or tendon |
What does dissection show about spread?
That product travels along planes, not as a sphere: on bone it runs along the periosteum and stops at ligament attachments; in deep fat it fills the compartment; in superficial fat it pools one layer too high. The third pattern is the one the masterclass's demonstration addresses under avoiding incorrect planes to prevent nodule and granuloma formation, and seeing it once on tissue is a stronger correction than reading about it.
Dissection also shows the spread in relation to the vessels. The Global Aesthetics Consensus Group's recommendations on hyaluronic acid complications (2016) list inappropriate placement of filler material among the early adverse reactions and nodules and granulomas among the late ones, and attribute most avoidable events to planning, anatomical understanding and technique; the same logic governs a biostimulator placed with a cannula or needle.
How do CaHA and PLLA differ at the bench?
Calcium hydroxylapatite is supplied as a gel suspension and used either as a structural product or hyperdiluted for skin quality; poly-L-lactic acid is reconstituted into a suspension before use and placed to stimulate collagen over the following weeks. The masterclass's biostimulator demonstration covers the mechanisms of action of both, avoiding incorrect planes to prevent nodule and granuloma formation, and the principles of dilution and hyperdilution.
On cadaveric tissue both are injected as dyed training products so that their distribution can be compared region by region; the lesson is the pattern, not the brand, and the teaching stays generic.
How does the masterclass teach biostimulators?
On the second afternoon: the instructor's demonstration of calcium hydroxylapatite and poly-L-lactic acid, then hands-on injection by every participant in the regions listed above, then dissection of the injected regions. The morning is given to hyaluronic acid fillers across nine regions, so the biostimulator block closes the course and the dissection that follows it examines the participants' filler injections as well. Between three and six participants share one fresh-frozen cadaver head. The programme facts for the ATDERA edition of March 2027 are tabulated below. ATDERA is the organiser and coordinator of the masterclass; the course director and faculty deliver the teaching in an anatomy laboratory in Ankara; where a credential is involved, the accrediting body is a separate third party — and for this masterclass no accreditation is claimed.
| Field | Detail | Where to verify |
|---|---|---|
| Dates and venue | Saturday 27 and Sunday 28 March 2027; TORLAK & TunaliS Anatomy Institute Joint Lab, Ankara | Programme page: hero and laboratory section |
| Language and group | English; up to six participants; between three and six participants share one fresh-frozen cadaver head | Programme page: at a glance |
| Eligibility | Licensed physicians; foundation-level injectables experience recommended; international registrations welcome; every application reviewed academically | Programme page: who should apply |
| Fee and what it covers | £2,100 per participant, collected in GBP after written acceptance; both laboratory days, dyed training products and consumables, personal protective equipment, lunch and coffee breaks; accommodation and transfers available separately on request | Programme page: fee section |
| Certificate and CPD | ATDERA certificate of attendance on attendance across both days and participation in every hands-on block; no CPD or CME credit is claimed | Programme page: certificate line and FAQ |
| Organiser and verification | ATDERA Global Limited, registered in England and Wales, Companies House number 17173428; ATDERA organises and coordinates, the course director and faculty deliver the teaching | Companies House register; programme page footer |
What are the limits of cadaveric teaching for biostimulators?
A cadaver shows placement, not response. The collagen stimulation that defines a biostimulator happens over weeks in living tissue and cannot be observed on a specimen; nor can nodule formation, which is a tissue reaction rather than a placement event alone. What cadaveric teaching verifies is the decision the injector controls: plane, distribution and distance from vessels.
A cadaver study of deep neck contouring and submandibular gland vascularity, co-authored by the course director and published in Aesthetic Surgery Journal (2023), illustrates the kind of regional dissection that turns a plane name into a map for the lower face and neck.
